SCHEMBL9100124

SCHEMBL9100124

Cc1ccc2c(c1)Oc1ncc(O)cc1C(=O)N2C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 2/20 0.40
NR1H3 Q13133 2/20 0.40
AURKA O14965 3/20 0.36
AURKB Q96GD4 3/20 0.36
PIK3CD O00329 2/20 0.36
PIK3C2G O75747 2/20 0.36
PIK3CG P48736 2/20 0.36
EGFR P00533 1/20 0.35
BRD4 O60885 3/20 0.35
MAPT P10636 2/20 0.35
MAPK7 Q13164 1/20 0.35
LMNA P02545 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
POLB P06746 1/20 0.35
PKM P14618 1/20 0.34
CNR1 P21554 1/20 0.34
GPR55 Q9Y2T6 1/20 0.34
PLK4 O00444 2/20 0.34
LRRK2 Q5S007 2/20 0.34
AURKC Q9UQB9 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9103407 0.85 PIK3CD (0.38) NR1H2NR1H3AURKAAURKBPIK3CD
SCHEMBL9101244 0.81 CASP1 (0.45) NR1H2NR1H3AURKAAURKBPIK3CD
SCHEMBL9101978 0.80 MAPT (0.53) MAPTLMNASMN1; SMN2POLBMEN1
SCHEMBL9004267 0.69 NR1H2 (0.47) NR1H2NR1H3AURKAAURKBPIK3CD
SCHEMBL9927344 0.67 NISCH (0.36) NR1H2NR1H3MAPTLMNAPOLB
SCHEMBL3500360 0.66 MAPT (0.50) AURKAAURKBBRD4MAPTLMNA
SCHEMBL10205375 0.66 CA1 (0.50) NR1H2NR1H3AURKAAURKBPIK3CD
SCHEMBL24704311 0.65 NISCH (0.33) MAPTPKMCNR1GPR55MEN1
SCHEMBL9100099 0.65 RAF1 (0.32) MAPTPOLBMEN1KMT2A
SCHEMBL9004285 0.65 CASP3 (0.56) NR1H2NR1H3PIK3CDPIK3CGMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5550122-A INHIBIT REVERSE TRANSCRIPTASE BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1996-08-27 US disclosed
EP-0415303-B1 Pyrido [2,3-b][1,5]benzoxazepin (and thiazepin)-5(6H)-ones and -thiones and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMA (US) 1995-12-13 EP disclosed
EP-0415303-A2 Pyrido [2,3-b][1,5]benzoxazepin (and thiazepin)-5(6H)-ones and -thiones and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 1991-03-06 EP disclosed